semaglutide and hair Loss: What the Science Shows I lose this much every

Key Takeaways If you want to learn more about medication-assisted weight loss, Mochi Health has board-certified obesity medicine physicians who can offer expert guidance

16 HOW SUPPLIED/STORAGE AND HANDLING How Supplied Single-patient-use pens (with multiple weekly doses): Injection: clear, colorless solution of 0.68 mg/mL, 1.34 mg/mL or 2.68 mg/mL of semaglutide available in the following packaging configurations: Each OZEMPIC multi-dose pen is for use by a single patient

*In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)

Both medications belong to the class of glucagon-like peptide 1 (GLP-1) agonists, which are approved for the treatment of type 2 diabetes

Dosing schedule and titration protocol Semaglutide titration follows a stepped approach designed to minimize gastrointestinal side effects